Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Universal Technical Institute Inc’s stock clocked out at $26.56, up 2.04% from its previous closing price of $26.03. In other words, the price has increased by $2.04 from its previous closing price. On the day, 1.22 million shares were traded. UTI stock price reached its highest trading level at $26.585 during the session, while it also had its lowest trading level at $25.895.
Ratios:
To gain a deeper understanding of UTI’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.34. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 0.85 whereas as Long-Term Debt/Eq ratio is at 0.78.
On July 25, 2024, Truist started tracking the stock assigning a Buy rating and target price of $22.
On January 10, 2024, Northland Capital started tracking the stock assigning a Outperform rating and target price of $16.Northland Capital initiated its Outperform rating on January 10, 2024, with a $16 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 12 ’25 when DEVINCENZI ROBERT THOMAS bought 10,000 shares for $25.40 per share. The transaction valued at 253,991 led to the insider holds 136,765 shares of the business.
Coliseum Capital Management, L sold 500,000 shares of UTI for $17,500,000 on May 27 ’25. The Director now owns 2,716,267 shares after completing the transaction at $35.00 per share. On May 15 ’25, another insider, Hitchcock Todd A, who serves as the EVP/COO of the company, sold 27,500 shares for $33.36 each. As a result, the insider received 917,471 and left with 80,521 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UTI now has a Market Capitalization of 1445490816 and an Enterprise Value of 1588176128. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.34, and their Forward P/E ratio for the next fiscal year is 26.48. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.24. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.79 while its Price-to-Book (P/B) ratio in mrq is 4.71. Its current Enterprise Value per Revenue stands at 1.962 whereas that against EBITDA is 13.595.
Stock Price History:
The Beta on a monthly basis for UTI is 1.66, which has changed by 0.5894674 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, UTI has reached a high of $36.32, while it has fallen to a 52-week low of $15.14. The 50-Day Moving Average of the stock is -15.74%, while the 200-Day Moving Average is calculated to be -5.40%.
Shares Statistics:
It appears that UTI traded 780.59K shares on average per day over the past three months and 1358750 shares per day over the past ten days. A total of 54.42M shares are outstanding, with a floating share count of 52.28M. Insiders hold about 3.62% of the company’s shares, while institutions hold 92.95% stake in the company. Shares short for UTI as of 1753920000 were 2384014 with a Short Ratio of 3.05, compared to 1751241600 on 2717608. Therefore, it implies a Short% of Shares Outstanding of 2384014 and a Short% of Float of 5.1599998000000005.
Earnings Estimates
Current recommendations for the stock of the company come from 6.0 analysts. The consensus estimate for the next quarter is $0.24, with high estimates of $0.29 and low estimates of $0.17.
Analysts are recommending an EPS of between $1.11 and $1.02 for the fiscal current year, implying an average EPS of $1.06. EPS for the following year is $1.0, with 6.0 analysts recommending between $1.1 and $0.9.
Revenue Estimates
In the current quarter, 6 analysts expect revenue to total $219.32M. It ranges from a high estimate of $220.6M to a low estimate of $216.8M. As of the current estimate, Universal Technical Institute Inc’s year-ago sales were $196.36MFor the next quarter, 6 analysts are estimating revenue of $219.6M. There is a high estimate of $226.71M for the next quarter, whereas the lowest estimate is $214.91M.
A total of 6 analysts have provided revenue estimates for UTI’s current fiscal year. The highest revenue estimate was $833.77M, while the lowest revenue estimate was $830M, resulting in an average revenue estimate of $832.49M. In the same quarter a year ago, actual revenue was $732.69MBased on 6 analysts’ estimates, the company’s revenue will be $906.69M in the next fiscal year. The high estimate is $930.21M and the low estimate is $900M.
